73 related articles for article (PubMed ID: 22213819)
1. Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.
Hatt M; Le Pogam A; Visvikis D; Pradier O; Cheze Le Rest C
J Nucl Med; 2012 Jan; 53(1):12-20. PubMed ID: 22213819
[TBL] [Abstract][Full Text] [Related]
2. Correction to: The "Weekday Effect"-Does It Impact Esophageal Cancer Surgery Outcomes?
Jiwnani S; Pramesh CS; Ranganathan P
J Gastrointest Cancer; 2023 Sep; 54(3):978. PubMed ID: 36074329
[No Abstract] [Full Text] [Related]
3. The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods.
Hosseini SA; Shiri I; Ghaffarian P; Hajianfar G; Avval AH; Seyfi M; Servaes S; Rosa-Neto P; Zaidi H; Ay MR
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38575814
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of
Shen DH; Chan HP; Tsai FR; Hu C; Chen AY; Chan HY; Lee CH; Chuang KP; Yang MH; Tyan YC
Metabolites; 2021 Dec; 12(1):. PubMed ID: 35050129
[TBL] [Abstract][Full Text] [Related]
5. Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning.
Pontoriero AD; Nordio G; Easmin R; Giacomel A; Santangelo B; Jahuar S; Bonoldi I; Rogdaki M; Turkheimer F; Howes O; Veronese M
Comput Methods Programs Biomed; 2021 Sep; 208():106239. PubMed ID: 34289438
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of an accurate CNR-guided small region iterative restoration-based tumor segmentation scheme for PET using both simulated and real heterogeneous tumors.
Koç A; Güveniş A
Med Biol Eng Comput; 2020 Feb; 58(2):335-355. PubMed ID: 31848977
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Metabolic Parameters and Textural Features on
Chang CC; Chen CJ; Hsu WL; Chang SM; Huang YF; Tyan YC
Sci Rep; 2019 Jul; 9(1):10946. PubMed ID: 31358786
[TBL] [Abstract][Full Text] [Related]
8. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using
Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for esophageal carcinoma: dose, response and survival.
Luo Y; Mao Q; Wang X; Yu J; Li M
Cancer Manag Res; 2018; 10():13-21. PubMed ID: 29343986
[TBL] [Abstract][Full Text] [Related]
10. Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.
Cysouw MCF; Kramer GM; Schoonmade LJ; Boellaard R; de Vet HCW; Hoekstra OS
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2105-2116. PubMed ID: 28776088
[TBL] [Abstract][Full Text] [Related]
11. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
[TBL] [Abstract][Full Text] [Related]
12. The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.
Shiri I; Rahmim A; Ghaffarian P; Geramifar P; Abdollahi H; Bitarafan-Rajabi A
Eur Radiol; 2017 Nov; 27(11):4498-4509. PubMed ID: 28567548
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
Dubreuil J; Giammarile F; Rousset P; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364
[TBL] [Abstract][Full Text] [Related]
14. Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.
Hong JH; Kim HH; Han EJ; Byun JH; Jang HS; Choi EK; Kang JH; Yoo IeR
J Korean Med Sci; 2016 Jan; 31(1):39-46. PubMed ID: 26770036
[TBL] [Abstract][Full Text] [Related]
15. A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
Rahmim A; Schmidtlein CR; Jackson A; Sheikhbahaei S; Marcus C; Ashrafinia S; Soltani M; Subramaniam RM
Phys Med Biol; 2016 Jan; 61(1):227-42. PubMed ID: 26639024
[TBL] [Abstract][Full Text] [Related]
16. Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Nishimura G; Komatsu M; Hata M; Yabuki K; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
Int J Clin Oncol; 2016 Apr; 21(2):224-230. PubMed ID: 26272533
[TBL] [Abstract][Full Text] [Related]
17. High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
Kim BH; Kim SJ; Kim K; Kim H; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
Ann Nucl Med; 2015 Oct; 29(8):721-9. PubMed ID: 26108700
[TBL] [Abstract][Full Text] [Related]
18. Optimising delineation accuracy of tumours in PET for radiotherapy planning using blind deconvolution.
Guvenis A; Koc A
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):495-8. PubMed ID: 25836686
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.
Hussien AE; Furth C; Schönberger S; Hundsdoerfer P; Steffen IG; Amthauer H; Müller HW; Hautzel H
Cancers (Basel); 2015 Jan; 7(1):287-304. PubMed ID: 25635760
[TBL] [Abstract][Full Text] [Related]
20. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
Lindner K; Palmes D; Senninger N; Hummel R
Langenbecks Arch Surg; 2015 Feb; 400(2):229-35. PubMed ID: 25572665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
